CYSTECTOMY FOR BLADDER CANCER: A CONTEMPORARY SERIES

2001432 citationsJournal Article

Authors

Guido Dalbagni · Hospital of the University of Pennsylvania

Elizabeth M. Genega · Memorial Sloan Kettering Cancer Center

Mia Hashibe · University of California, Los Angeles

Zuo‐Feng Zhang · Memorial Sloan Kettering Cancer Center

Paul Russo · University of California, Los Angeles

Harry W. Herr · Hospital of the University of Pennsylvania

Victor Reuter

Abstract

Bladder cancer can be categorized into organ confined and nonorgan confined tumors. This dichotomous grouping is better suited for evaluating adjuvant clinical trials. The pT stage of the bladder and prostate should be prospectively analyzed together to better define the clinical implications of prostatic involvement. In our opinion the histological subtypes do not affect outcome.

Topics & Keywords

Bladder and Urothelial Cancer Treatments Urinary and Genital Oncology Studies Renal cell carcinoma treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Journal of Urology

Volume 165, Issue 4, pp. 1111-1116

DOI: 10.1016/s0022-5347(05)66440-3

Field-Weighted Citation Impact: 16.16